PremiumCompany AnnouncementsiSpecimen Appoints Robert Lim as New CEO iSpecimen Inc. Reports Earnings Amid Financial Challenges iSpecimen releases cancer biospecimen offering PremiumCompany AnnouncementsiSpecimen Faces Ex-Executive’s Financial Claims, Regains Nasdaq Compliance iSpecimen secures $1M loan, appoints three board members iSpecimen Bolsters Finance with Loan and Board Revamp PremiumCompany AnnouncementsiSpecimen Announces Reverse Stock Split for Compliance and Appeal iSpecimen announces 1-for-20 reverse stock split Craig-Hallum bullish on iSpecimen as Next Day Quoting fuels revene growth